Lipid-rich diet enhances L-cell density in obese subjects and in mice through improved L-cell differentiation.
J Nutr Sci
; 4: e22, 2015.
Article
em En
| MEDLINE
| ID: mdl-26157580
The enterohormone glucagon-like peptide-1 (GLP-1) is required to amplify glucose-induced insulin secretion that facilitates peripheral glucose utilisation. Alteration in GLP-1 secretion during obesity has been reported but is still controversial. Due to the high adaptability of intestinal cells to environmental changes, we hypothesised that the density of GLP-1-producing cells could be modified by nutritional factors to prevent the deterioration of metabolic condition in obesity. We quantified L-cell density in jejunum samples collected during Roux-en-Y gastric bypass in forty-nine severely obese subjects analysed according to their fat consumption. In mice, we deciphered the mechanisms by which a high-fat diet (HFD) makes an impact on enteroendocrine cell density and function. L-cell density in the jejunum was higher in obese subjects consuming >30 % fat compared with low fat eaters. Mice fed a HFD for 8 weeks displayed an increase in GLP-1-positive cells in the jejunum and colon accordingly to GLP-1 secretion. The regulation by the HFD appears specific to GLP-1-producing cells, as the number of PYY (peptide YY)-positive cells remained unchanged. Moreover, genetically obese ob/ob mice did not show alteration of GLP-1-positive cell density in the jejunum or colon, suggesting that obesity per se is not sufficient to trigger the mechanism. The higher L-cell density in HFD-fed mice involved a rise in L-cell terminal differentiation as witnessed by the increased expression of transcription factors downstream of neurogenin3 (Ngn3). We suggest that the observed increase in GLP-1-positive cell density triggered by high fat consumption in humans and mice might favour insulin secretion and therefore constitute an adaptive response of the intestine to balance diet-induced insulin resistance.
BrdU, bromodeoxyuridine; CD, control diet; Enteroendocrine cells; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide-1; Gut hormones; HFD, high-fat diet; High-fat diet; Intestine; PYY, peptide YY; foxa1, forkhead box protein A1; foxa2, forkhead box protein A2; isl1, insulin gene enhancer protein-1; ngn3, neurogenin3; pax6, paired box protein-6
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
J Nutr Sci
Ano de publicação:
2015
Tipo de documento:
Article
País de afiliação:
França